- --------------------------------------------------------------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------
FORM 4
------ OMB APPROVAL
[_] Check this box if no -------------------------
longer subject to Section OMB Number: 3235-0287
16. Form 4 or Form 5 STATEMENT OF CHANGES -------------------------
obligations may continue. IN BENEFICIAL OWNERSHIP Expires: January 31, 2005
See Instruction 1(b). -------------------------
Estimated average burden
(Print or Type Responses) hours per response ...0.5
-------------------------
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30
(f) of the Investment Company Act of 1940
- --------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Stark, Stevan R.
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Laboratory Corporation of America
430 South Spring Street
- --------------------------------------------------------------------------------
(Street)
Burlington, North Carolina 27215
- --------------------------------------------------------------------------------
(City) (State) (Zip)
- --------------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
Laboratory Corporation of America Holdings ("LH")
- --------------------------------------------------------------------------------
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary)
- --------------------------------------------------------------------------------
4. Statement for Month/Year
April 2002
- --------------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
- --------------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
______ Director ______ 10% Owner
X Officer (give title below) ______ Other (specify below)
------
Executive Vice President
------------------------
- --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
---
___ Form filed by More than One Reporting Person
- --------------------------------------------------------------------------------
Table 1 - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Transaction 3. Transaction 4. Securities Acquired(A) 5. Amount of 6.Ownership 7. Nature of
(Instr. 3) Date Code or Disposed of (D) Securities Form: Indirect
(Month/Day/ (Instr.8) (Instr.3, 4 and 5) Beneficially Direct (D) Beneficial
Year) ------------------------------------------ Owned at End or Indirect Ownership
of Month (I)
Code V Amount (A) or (D) Price (Instr.3 and 4) (Instr.4) (Instr.4)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 4/2/02 S 1,700 D $95.18
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 4/2/02 S 800 D $95.24
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 4/2/02 S 4,600 D $95.50
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 4/2/02 S 400 D $95.76
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 4/2/02 S 7,700 D $95.86
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 4/2/02 S 2,500 D $96.00
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock(1) 4/19/02 M 5,000 A $65.00
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock(1) 4/19/02 M 9,067 A $66.125
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock(1) 4/19/02 S 14,067 D $100.00 53,316.3570 D
- ------------------------------------------------------------------------------------------------------------------------------------
(1) Transactions indicated were pursuant to a plan in compliance with Rule
10b5-1 under the Securities Exchange Act of 1934.
- --------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------
Table II-- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------
1. Title of 2. Conversion 3. Transaction 4. Transaction 5. Number 6. Date Exerciseable 7. Title and
Derivative or Exercise Date Code of Expiration Date Amount of
Security Price of (Month/Day (Instr. 8) Derivative (Month/Day/Year) Underlying
(Instr.3) Derivative Year) Securities Securities
Security Acquired (Instr. 3
(A) or and 4)
Disposed
of (D)
(Instr. 3,
4 and 5)
--------------------------------------------------------------------------
Amount
or
Date Number
Exercis- Expiration Title of
Code V (A) (D) able Date Common Shares
- ------------------------------------------------------------------------------------------------------------------------
Employee Stock $65.00 4/19/02 M 5,000 (3) 6/28/05 Common 5,000
Option (1)(2) Stock
- ------------------------------------------------------------------------------------------------------------------------
Employee Stock $66.125 4/19/02 M 9,067 (5) 2/6/11 Common 9,067
Option (2) (4) Stock
- ------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------
8. Price of Derivative 9. Number of 10. Ownership 11. Nature of
Security Derivative Form of Indirect
(Instr. 5) Securities Derivative Beneficial
Beneficially Securities Ownership
Owned at End of Beneficially (Instr. 4)
Month Owned at End
(Instr. 4) of Month
(Instr. 4)
- ---------------------------------------------------------------------------------------
0
- ---------------------------------------------------------------------------------------
18,133 D
- ---------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------
Explanation of Responses:
(1) Common stock purchase option granted under the Laboratory Corporation of
America Holdings 1994 Stock Option Plan.
(2) Transactions indicated were pursuant to a plan in compliance with Rule
10b5-1 under the Securities Exchange Act of 1934.
(3) Total option to purchase 5,000 shares vested in three approximately equal
installments on June 28, 1995, June 28, 1996 and June 28, 1997.
(4) Common stock purchase option granted under the Laboratory Corporation of
America Holdings 2000 Stock Incentive Plan.
(5) Total option to purchase 27,200 shares vests in three approximately equal
installments on February 5, 2002, February 5, 2003 and February 5, 2004.
/s/ Bradford T. Smith
--------------------------------
**Signature of Reporting Person May 6, 2002
Bradford T. Smith, Attorney-in-Fact for -----------
Date
Stevan R. Stark
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see
Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure
